[Local bullous eruption after extravasation of iodine contrast product].

M. Carreiro, P. Arlet(Centre de Référence Déficits Immunitaires Héréditaires), Patricia Chemla, L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), Nathalie Margarit-Coll, Serge Dahan(Unknown)

PubMed

May 31, 2003

Cited by 0

Related Papers

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

|British Journal of Dermatology|2021|414

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

|Journal of Allergy and Clinical Immunology|2017|316

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

|Annals of the Rheumatic Diseases|2012|207

Nonablative Remodeling: Clinical, Histologic, Ultrasound Imaging, and Profilometric Evaluation of a 1540 nm Er:Glass Laser

|Dermatologic Surgery|2001|155

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

|Arthritis & Rheumatology|2015|140